Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AFYA
stocks logo

AFYA

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
934.97M
+15.44%
2.066
-9.78%
925.79M
+10.06%
1.818
+1.56%
934.96M
+10.12%
2.206
+5.06%
Estimates Revision
The market is revising Upward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by 0.67% over the past three months. During the same period, the stock price has changed by -15.41%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.67%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+4.2%
In Past 3 Month
Stock Price
Go Down
down Image
-15.41%
In Past 3 Month
3 Analyst Rating
up Image0
Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.67 USD with a low forecast of 19.00 USD and a high forecast of 23.50  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
1 Sell
Moderate Sell
up Image0
Current: 15.395
sliders
Low
19.00
Averages
20.67
High
23.50
up Image0
Current: 15.395
sliders
Low
19.00
Averages
20.67
High
23.50
UBS
Neutral
maintain
2025-06-12
Reason
UBS
Price Target
2025-06-12
maintain
Neutral
Reason
UBS raised the firm's price target on Afya to $19.50 from $17.50 and keeps a Neutral rating on the shares. Positive momentum on growth and margins seems fairly priced in, the analyst tells investors in a research note.
Morgan Stanley
Mauricio Cepeda
Hold
to
Sell
Downgrades
$19 → $17
2025-03-11
Reason
Morgan Stanley
Mauricio Cepeda
Price Target
$19 → $17
2025-03-11
Downgrades
Hold
to
Sell
Reason
Citigroup
Leandro Bastos
Hold
to
Strong Sell
Downgrades
$18 → $15
2025-01-31
Reason
Citigroup
Leandro Bastos
Price Target
$18 → $15
2025-01-31
Downgrades
Hold
to
Strong Sell
Reason
JP Morgan
Marcelo Santos
Hold
Maintains
$25 → $21
2025-01-17
Reason
JP Morgan
Marcelo Santos
Price Target
$25 → $21
2025-01-17
Maintains
Hold
Reason
Goldman Sachs
Gustavo Miele
Strong Sell
Initiates
$16
2024-12-03
Reason
Goldman Sachs
Gustavo Miele
Price Target
$16
2024-12-03
Initiates
Strong Sell
Reason
Goldman Sachs initiated coverage of Afya with a Sell rating and $16 price target. Afya is the largest medical education ecosystem in Brazil, the analyst tells investors in a research note. The firm says Afya's integration skills, solid brands, scale and relatively light balance sheet position the company as the main consolidator in the market, but it remains cautious on the economics of undergrad medical seats. AFYA's valuation premium to the rest of the sector is stretched at current levels, contends Goldman.
UBS
Andre Salles
Hold
Initiates
$20
2024-08-30
Reason
UBS
Andre Salles
Price Target
$20
2024-08-30
Initiates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Afya Ltd (AFYA.O) is 9.25, compared to its 5-year average forward P/E of 15.77. For a more detailed relative valuation and DCF analysis to assess Afya Ltd 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
15.77
Current PE
9.25
Overvalued PE
22.66
Undervalued PE
8.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
9.67
Current EV/EBITDA
5.70
Overvalued EV/EBITDA
13.77
Undervalued EV/EBITDA
5.56

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
3.65
Current PS
2.04
Overvalued PS
5.78
Undervalued PS
1.51

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

AFYA News & Events

Events Timeline

(ET)
2025-03-13
17:51:43
Afya sees FY25 revenue R$3.67B-R$3.77B
select
2025-03-13
17:50:05
Afya reports Q4 adjusted EPS R$2.10 vs. R$1.79 last year
select
2024-11-13 (ET)
2024-11-13
16:53:21
Afya backs FY24 revenue view R$3.23B-R$3.33B
select
Sign Up For More Events
Sign Up For More Events

News

Preview
6.0
06-23NASDAQ.COM
New Strong Buy Stocks for June 23rd

  • Strong Buy Stocks: Five stocks have been added to the Zacks Rank #1 (Strong Buy) List, including Dundee Precious Metals, Eldorado Gold, Afya, Allison Transmission Holdings, and Horace Mann Educators, all of which have seen significant increases in their earnings estimates over the past 60 days.

  • Investment Recommendations: Zacks Investment Research highlights a satellite-based communications firm as a top pick with potential for substantial revenue growth, projecting it could outperform previous successful stocks like Hims & Hers Health.

Preview
6.0
06-12Benzinga
UBS Maintains Neutral on Afya, Raises Price Target to $19.5

  • Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and real-time intelligence to help traders succeed in the stock market.

  • Exclusive Community Access: Joining Benzinga Pro connects you with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

Preview
4.0
06-07NASDAQ.COM
Validea Martin Zweig Strategy Daily Upgrade Report - 6/7/2025

  • Yelp Inc. Rating Update: Yelp Inc. has seen its rating increase from 46% to 85% based on Martin Zweig's growth stock strategy, indicating strong interest due to its solid fundamentals and valuation in the Business Services industry.

  • Afya Ltd. Rating Update: Afya Ltd. also experienced a rating boost from 69% to 85%, reflecting favorable underlying fundamentals and valuation as a small-cap value stock in the education sector, particularly focused on medical training in Brazil.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Afya Ltd (AFYA) stock price today?

The current price of AFYA is 15.395 USD — it has increased 0.88 % in the last trading day.

arrow icon

What is Afya Ltd (AFYA)'s business?

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

arrow icon

What is the price predicton of AFYA Stock?

Wall Street analysts forecast AFYA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AFYA is 20.67 USD with a low forecast of 19.00 USD and a high forecast of 23.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Afya Ltd (AFYA)'s revenue for the last quarter?

Afya Ltd revenue for the last quarter amounts to 936.36M USD, increased 16.43 % YoY.

arrow icon

What is Afya Ltd (AFYA)'s earnings per share (EPS) for the last quarter?

Afya Ltd. EPS for the last quarter amounts to 2.76 USD, increased 24.32 % YoY.

arrow icon

What changes have occurred in the market's expectations for Afya Ltd (AFYA)'s fundamentals?

The market is revising Upward the revenue expectations for Afya Limited (AFYA) for FY2025, with the revenue forecasts being adjusted by 0.67% over the past three months. During the same period, the stock price has changed by -15.41%.
arrow icon

How many employees does Afya Ltd (AFYA). have?

Afya Ltd (AFYA) has 9717 emplpoyees as of July 18 2025.

arrow icon

What is Afya Ltd (AFYA) market cap?

Today AFYA has the market capitalization of 1.43B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free